Thoma Bravo buys Greenphire from Riverside
Jim Murphy, CEO of Greenphire, will continue to lead the clinical trial payments company along with the existing management team.
Jim Murphy, CEO of Greenphire, will continue to lead the clinical trial payments company along with the existing management team.